NEDNA Trademark

Trademark Overview

On Tuesday, May 9, 2023, a trademark application was filed for NEDNA with the United States Patent and Trademark Office. The USPTO has given the NEDNA trademark a serial number of 97927503. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Friday, February 13, 2026. This trademark is owned by Asklepios BioPharmaceutical, Inc.. The NEDNA trademark is filed in the Pharmaceutical Products category with the following description:

DNA extracts, namely, nucleic acid sequences for medical use; Therapeutic DNA, namely, nucleic acid sequences for medical and veterinary purposes; Biological preparations, namely, rAAV vectors and DNA extracts for production of DNA vectors and viral vectors for medical purposes
nedna

General Information

Serial Number97927503
Word MarkNEDNA
Filing DateTuesday, May 9, 2023
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateFriday, February 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesDNA extracts, namely, nucleic acid sequences for medical use; Therapeutic DNA, namely, nucleic acid sequences for medical and veterinary purposes; Biological preparations, namely, rAAV vectors and DNA extracts for production of DNA vectors and viral vectors for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateWednesday, November 30, 2022
First Use In Commerce DateSaturday, May 31, 2025

Trademark Owner History

Party NameAsklepios BioPharmaceutical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameAsklepios BioPharmaceutical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2024ASSIGNED TO EXAMINER
Tuesday, February 6, 2024PRIORITY ACTION WRITTEN
Tuesday, February 6, 2024PRIORITY ACTION E-MAILED
Tuesday, February 6, 2024NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, February 7, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 7, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 7, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024SOU EXTENSION 1 FILED
Tuesday, November 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 7, 2025SOU EXTENSION 2 FILED
Wednesday, May 7, 2025SOU EXTENSION 2 GRANTED
Thursday, May 8, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 22, 2025TEAS STATEMENT OF USE RECEIVED
Monday, January 26, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 22, 2025USE AMENDMENT FILED
Monday, January 26, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, February 13, 2026SU - NON-FINAL ACTION - WRITTEN
Friday, February 13, 2026NON-FINAL ACTION E-MAILED
Friday, February 13, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

nedna vectors medical namely extracts nucleic acid sequences purposes production viral